Skip to content

Rational Fluid Therapy in Germany

Klinisches Register RaFTinG - Rational Fluid Therapy in Germany

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01122277
Acronym
RaFTinG
Enrollment
4000
Registered
2010-05-13
Start date
2010-05-31
Completion date
2011-10-31
Last updated
2011-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients in ICU

Keywords

Volume therapy, Fluid therapy, Patients in ICU

Brief summary

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Detailed description

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany. Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Interventions

None listed

Sponsors

University Hospital Muenster
CollaboratorOTHER
Fresenius Kabi, Bad Homburg, Germany
CollaboratorUNKNOWN
Ludwig-Maximilians - University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ICU patients with an indication for fluid/volume therapy

Exclusion criteria

* Patients hospitalized by order of a court of law or a government agency

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026